A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Sidner announced during a broadcast that she had been diagnosed with stage III breast cancer, urging women to get screened.

Stage actress Kara Lindsay is "celebrating closing [a] massive chapter" after revealing her breast cancer diagnosis. The ...

Researchers reporting in ACS Central Science have created a novel treatment that eliminated small-sized breast tumours and ...

Retired Vista fire captain Bob Stacey and his friend Bob Nunez walked 15 miles in one day to raise awareness for Firefighter ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

Researchers are exploring how to prolong ovarian life and revisiting hormone replacement therapy — a once routine treatment that has fallen out of favour.